{"id":"W4403904602","doi":"10.1016/j.jtho.2024.10.012","title":"Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Santé Montérégie","funders":"","keywords":"Pembrolizumab; Medicine; Chemotherapy; Olaparib; Oncology; Internal medicine; Lung cancer; Cancer; Immunotherapy; Polymerase; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003218321,0.0002431594,0.0006761666,0.0002482665,0.0003908011,0.0003544228,0.0003145444,0.0004366075,0.002078638],"category_scores_gemma":[0.0004706637,0.0001053745,0.0007352715,0.0002373187,0.0002059344,0.0003456229,0.0001539358,0.0009832025,0.0002895683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007437553,"about_ca_system_score_gemma":0.0004538958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001046051,"about_ca_topic_score_gemma":0.002900313,"domain_scores_codex":[0.9998922,0.00001722574,0.00001176003,0.00002118271,0.00001353505,0.00004398554],"domain_scores_gemma":[0.9999074,0.00002430933,0.000008097738,0.00000941608,0.000007909324,0.00004288674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1838511,0.00754841,0.03511654,0.001695622,0.001805677,0.02325892,0.0003652246,0.005559075,0.1320673,0.001464995,0.01491784,0.5923494],"study_design_scores_gemma":[0.08130644,0.2289071,0.3767766,0.000811033,0.005450055,0.06308829,0.0008305401,0.02659151,0.1050649,0.003195119,0.1077337,0.0002447514],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872254,0.00518069,0.000625084,0.001124981,0.0003532009,0.0003699448,0.0004147108,0.0000618578,0.004644242],"genre_scores_gemma":[0.996439,0.001241528,0.0005496019,0.000392275,0.00008027031,0.0000964954,0.0003559656,0.000007896651,0.0008368568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002078638,"threshold_uncertainty_score":0.006953776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06185208516748933,"score_gpt":0.4462156689385008,"score_spread":0.3843635837710114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}